CTSO
Cytosorbents CorpCompany with tickers: CTSO
CIK
1175151
CUSIP
23283X206
Shares Outstanding
62,794,748
13F Activity (30d)
41 filings
41 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $6,130,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $9,174,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $1,025,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-3,044,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-5,129,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |